For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results